Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cerus Corporation (CERS)

5.14   -0.04 (-0.77%) 02-28 16:00
Open: 5.03 Pre. Close: 5.18
High: 5.2 Low: 4.85
Volume: 2,695,787 Market Cap: 834M
Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.21 - 5.24 5.24 - 5.272
Low: 4.771 - 4.802 4.802 - 4.836
Close: 5.078 - 5.135 5.135 - 5.197

Technical analysis

as of: 2020-02-28 4:27:10 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 6.42     One year: 7.50
Support: Support1: 4.54    Support2: 3.94
Resistance: Resistance1: 5.50    Resistance2: 6.42
Pivot: 4.99
Moving Average: MA(5): 5.10     MA(20): 4.89
MA(100): 4.42     MA(250): 5.09
MACD: MACD(12,26): 0.19     Signal(9): 0.18
Stochastic oscillator: %K(14,3): 66.60     %D(3): 64.77
RSI: RSI(14): 57.66
52-week: High: 6.71  Low: 3.70  Change(%): -22.0
Average Vol(K): 3-Month: 157184  10-Days: 236365

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CERS has closed below upper band by 33.0%. Bollinger Bands are 23.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 30 Sep 2019 19:18:20 +0000
Noteworthy Monday Option Activity: SFIX, STAA, CERS

Tue, 06 Jan 2015 15:46:21 +0000
Mid-Morning Market Update: Markets Open Higher; Commercial Metals Posts Upbeat Earnings

Fri, 22 Feb 2019 15:06:17 +0000
Analysts Forecast 14% Upside For The Holdings of XHE

Mon, 30 Jul 2018 11:26:00 +0000
Zacks.com featured highlights include: OFG, Northern Oil, Sunrun, Cerus and Veracyte

Fri, 27 Jul 2018 12:41:00 +0000
5 Breakout Stocks Offering Stellar Returns

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 158.96
Shares Float (M) 129.52
% Held by Insiders 1.90
% Held by Institutions 66.57
Shares Short (K) 9920
Shares Short P. Month (K)

Stock Financials

EPS -0.513
Book Value (p.s.) 0.430
PEG Ratio
Profit Margin -100.38
Operating Margin -92.91
Return on Assets (ttm) -25.0
Return on Equity (ttm) -92.4
Qtrly Rev. Growth 17.0
Gross Profit (p.s.) 0.184
Sales Per Share
EBITDA (p.s.) -0.397
Qtrly Earnings Growth
Operating Cash Flow (M) -64.37
Levered Free Cash Flow (M) -47.66

Stock Valuations

P/E -10.02
P/E Growth Ratio -0.01
P/BV 11.95
P/S 10.07
P/CF -12.69

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.